The Latest Cardiac and Vascular News
DUBLIN, Sept. 23, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced first enrollments in the ALLEVIATE-HF clinical trial which will evaluate the ability of its Reveal LINQ™ Insertable Cardiac Monitor (ICM) in identifying patients at high-risk of worsening heart failure. The trial will determine if early […]
DUBLIN, Sept. 22, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the TYRX™ Absorbable Antibacterial Driveline Wrap, which is intended to securely hold a percutaneous driveline in patients receiving a ventricular assist device (VAD). […]
Funds Support Further Development of V-Wave Implantable Interatrial Cardiac Shunt for Heart Failure and Pulmonary Hypertension CAESAREA, Israel and AGOURA HILLS, Calif., Sept. 22, 2020 /PRNewswire/ — V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension (PAH), announced […]
SALINAS, Calif., Sept. 23, 2020 /PRNewswire/ — During unprecedented challenges in healthcare, Salinas Valley Memorial Healthcare System (SVMHS) is providing medical leadership during COVID-19 and earning awards for exceptional patient care in the area of heart treatment. SVMHS is one of only 60 hospitals nationwide to receive the American College of Cardiology’s NCDR […]
Company Advances Second Cardiac Myosin Inhibitor SOUTH SAN FRANCISCO, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first participants have been dosed in a Phase 1 placebo-controlled, single ascending dose clinical study of CK-3772271 (CK-271). CK-271 is a second cardiac myosin inhibitor, discovered […]
TEL AVIV, Israel, Sept. 23, 2020 (GLOBE NEWSWIRE) — OnSight Medical, a leading AI ultrasound company specializing in cardiology, today announced Rick Heinick will be joining its Board of Directors. Mr. Heinick is a recognized healthcare entrepreneur, who founded the ophthalmic pharmaceutical company TearClear, serving as its Executive Chairman for […]
Next-generation technology provides easy, effective clot removal from peripheral arterial vasculature EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Pounce™ Thrombus Retrieval System. […]
GENEVA–(BUSINESS WIRE)–EBAMed SA, a medical technology company based in Geneva, Switzerland, has been awarded EUR 2.4 million in a non-dilutive grant (agreement No. 954783) by the Enhanced European Innovation Council (EIC) to develop its cardiac motion management product for the non-invasive treatment of heart arrhythmias. The grant enables EBAMed to […]
Key appointment forms part of Creavo’s strategy to scale the Company Creavo’s Corsens® technology developed to improve patient care pathway in cardiac diagnostics COVENTRY, England–(BUSINESS WIRE)–Creavo Medical Technologies Ltd (Creavo), the medical device company developing innovative diagnostics techniques, has announced that it has appointed Martin Frost as Chairman of the […]
Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization under fluoroscopy FLAGSTAFF, Ariz., Sept. 22, 2020 /PRNewswire/ — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. (Gore) announced the U.S. launch of the lower profile, large […]
